Caladrius Biosciences
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $29,050,000.

Profit Margin

Caladrius Biosciences, Inc. (NASDAQ:CLBS): Profit margin
2012 14.32M -53.76M -375.23%
2013 14.66M -39.48M -269.19%
2014 17.93M -55.46M -309.2%
2015 22.48M -81.01M -360.25%
2016 35.28M -33.30M -94.4%
2017 0 -16.17M
2018 0 -16.17M
2019 0 -19.36M
2020 0 -8.14M
2021 0 -27.46M

CLBS Income Statement (2012 โ€“ 2021)

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012
Revenue
Revenue
0000035.28M22.48M17.93M14.66M14.32M
Cost of revenue
29.05M19.14M20.09M16.98M27.59B31.13M20.15M15.67M12.94M11.94M
Gross profit
-29.05M-19.14M-20.09M-16.98M-27.59B4.14M2.32M2.26M1.72M2.38M
Operating exp.
Research and development
17.68M9.25M10.79M7.59M15.84M15.10M23.89M29.19M16.91M10.45M
Selling and marketing
0000000000
Total operating expenses
29.05M19.14M20.09M16.98M27.59M35.48M53.90M60.00M38.53M32.76M
Operating income
-28.97M-19.02M-19.36M-16.16M11.82M-30.66M-96.00M-54.22M-37.91M-30.38M
Other income (expenses), net
56.59M19.27M9K-6K16.14B-2.51M15.59B55.41B-785.51K-5.89M
Income before tax
-28.97M-19.01M-19.35M-16.16M-27.69M-33.17M-98.25M-55.57M-38.70M-36.27M
Income tax expense
-1.50M-10.87M9K5K-11.52M138.03K-17.24M-104.20K780.10K-175.53K
Net income
-27.46M-8.14M-19.36M-16.17M-16.17M-33.30M-81.01M-55.46M-39.48M-53.76M
Earnings per share
Basic EPS
-1.78-0.53-1.88-1.67-1.8-5.09-16.7-16.93-19.27-40
Diluted EPS
-1.78-0.53-1.88-1.67-1.8-5.09-16.7-16.93-19.27-40
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source